Company / Inventory
Niagen Bioscience, Inc. Inventory History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$9.2M
FY2024
5-year range
$9.2M / $14.7M
FY2020-FY2024
Trend
-36.7%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $15M to $9M over the past 2 years.
Based on SEC 10-K filings.
$9M in FY2024 with a 5-year CAGR of -4.4%.
Declined from $15M to $9M over the past 2 years.
Inventory over time
Growth rates
- 3-Year CAGR
- -12.2%
- 5-Year CAGR
- -4.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -4.4%, indicating a declining trend.
- In FY2024, inventory decreased 36.7% year-over-year.
- Peak inventory was recorded in FY2022.
- Lowest inventory in the period was in FY2017.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $9.2M | -36.7% |
| FY2023 | $14.5M | -1.0% |
| FY2022 | $14.7M | +7.9% |
| FY2021 | $13.6M | +16.4% |
| FY2020 | $11.7M | +1.3% |
| FY2019 | $11.5M | +39.8% |
| FY2018 | $8.2M | +42.3% |
| FY2017 | $5.8M | -26.8% |
| FY2016 | $7.9M | -3.2% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026